# The role of prenatal maternal sex steroid hormones in weight and adiposity at birth and growth trajectories during infancy

**Authors:** Ying Meng, Loralei Thornburg, Caitlin Dreisbach, Charlotte Orzolek, Amber Kautz, Hannah Murphy, Zorimar Rivera- Núñez, Christina Wang, Richard Miller, Thomas O’Connor, Emily Barrett

PMC · DOI: 10.21203/rs.3.rs-4178000/v1 · Research Square · 2024-04-10

## TL;DR

This study shows that prenatal exposure to sex steroid hormones affects birth weight, body fat, and infant growth, with effects varying by hormone type, timing, and child sex.

## Contribution

The study identifies sex- and timing-specific associations between prenatal sex steroid hormones and infant growth outcomes.

## Key findings

- First trimester estrone is linked to higher birthweight and body fat in female infants.
- Third trimester testosterone is associated with increased body fat at birth in male infants.
- Higher testosterone in early and late pregnancy is linked to lower chances of high stable weight growth in male infants.

## Abstract

Intrauterine factors can impact fetal and child growth and may underlie the developmental origins of childhood obesity. Sex steroid hormone exposure during pregnancy is a plausible target because of the impact on placental vascularization, nutrient transportation, bone growth, adipogenesis, and epigenetic modifications. In this study we assessed maternal sex steroid hormones in each trimester in relation to birthweight, neonatal adiposity, and infant growth trajectories, and evaluate sensitive windows of development.

Participants from a prospective pregnancy cohort who delivered at term were included in the analysis (n=252). Estrone, estradiol, and estriol, as well as total and free testosterone throughout gestation were assessed using high-performance liquid chromatography and tandem mass spectrometry. Path analyses were used to assess the direct associations of sex steroid hormones in each trimester with birth outcomes and infant growth trajectories (birth to 12 months) adjusting for covariates and considering moderation by sex.

The associations between prenatal sex steroid hormones and fetal/infant growth varied by sex and hormone assessment timing. First trimester estrone were associated with higher birthweight z-scores (β=0.37, 95%CI: 0.02, 0.73) and truncal skinfold thickness (TST) at birth (β=0.94, 95%CI: 0.34, 1.54) in female infants. Third trimester total testosterone was associated with higher TST at birth (β=0.61, 95%CI: 0.02, 1.21) in male infants. First trimester estrone/estradiol and first and third trimesters testosterone were associated with lower probabilities of high stable weight trajectory compared to low stable weight trajectory (Estrone: β=−3.87, 95%CI: −6.59, −1.16; First trimester testosterone: β=−3.53, 95%CI: −6.63, −0.43; Third trimester testosterone: β=−3.67, 95%CI: −6.66, −0.69) during infancy in male infants.

We observed associations between prenatal sex steroid hormone exposure and birthweight, neonatal adiposity and infant growth that were sex and gestational timing dependent. Our findings suggest further investigation on additional mechanisms linking prenatal sex steroid exposure and fetal/postnatal growth is needed.

## Linked entities

- **Chemicals:** estrone (PubChem CID 5870), estradiol (PubChem CID 450), estriol (PubChem CID 5756), testosterone (PubChem CID 6013)

## Full-text entities

- **Diseases:** adiposity (MESH:D018205), obesity (MESH:D009765)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11042427/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11042427/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC11042427/full.md

---
Source: https://tomesphere.com/paper/PMC11042427